PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.440.14 (-2.51%)
5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.25%
Revenue growth above 1.5x HUH1V.HE's 5.02%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
44.98%
Gross profit growth above 1.5x HUH1V.HE's 13.55%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
21.04%
EBIT growth 1.25-1.5x HUH1V.HE's 16.69%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
21.04%
Operating income growth 1.25-1.5x HUH1V.HE's 16.69%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
60.67%
Net income growth above 1.5x HUH1V.HE's 13.99%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
63.16%
EPS growth above 1.5x HUH1V.HE's 12.50%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
63.16%
Diluted EPS growth above 1.5x HUH1V.HE's 12.50%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
-1.53%
Reduced diluted shares while HUH1V.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-22.70%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-40.00%
Negative FCF growth while HUH1V.HE is at 26.22%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-8.68%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 85.53%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
25.96%
5Y revenue/share CAGR at 50-75% of HUH1V.HE's 41.29%. Martin Whitman would worry about a lagging mid-term growth trajectory.
17.83%
3Y revenue/share CAGR at 50-75% of HUH1V.HE's 30.83%. Martin Whitman would question if the firm lags behind competitor innovations.
182.79%
10Y OCF/share CAGR under 50% of HUH1V.HE's 1010.65%. Michael Burry would worry about a persistent underperformance in cash creation.
247.97%
Positive OCF/share growth while HUH1V.HE is negative. John Neff might see a comparative advantage in operational cash viability.
150.87%
3Y OCF/share CAGR above 1.5x HUH1V.HE's 51.49%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
731.07%
Net income/share CAGR above 1.5x HUH1V.HE's 144.93% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
211.38%
5Y net income/share CAGR above 1.5x HUH1V.HE's 47.94%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
83.17%
3Y net income/share CAGR above 1.5x HUH1V.HE's 45.33%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
99.05%
10Y equity/share CAGR in line with HUH1V.HE's 97.96%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
57.70%
5Y equity/share CAGR 1.25-1.5x HUH1V.HE's 38.73%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
31.43%
3Y equity/share CAGR 1.25-1.5x HUH1V.HE's 27.01%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.89%
AR growth well above HUH1V.HE's 4.57%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.56%
Inventory growth well above HUH1V.HE's 16.70%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.44%
Similar asset growth to HUH1V.HE's 5.90%. Walter Schloss finds parallel expansions or investment rates.
0.10%
Under 50% of HUH1V.HE's 7.46%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
4.68%
Debt growth far above HUH1V.HE's 5.43%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Our R&D shrinks while HUH1V.HE invests at 1.33%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-3.65%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.